Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

host dendritic cell vaccine-001 MSSM/BIIR

A dendritic cell (DC) vaccine containing ex vivo expanded autologous DCs obtained from a patient with leukemia with potential immunostimulating activity. Upon reintroduction into the host, the host dendritic cell vaccine-001 MSSM/BIIR may stimulate the immune system to mount a leukemia-specific cytotoxic T lymphocyte (CTL) response.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:MSSM/BIIR HDC Vax-001
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search